大博医疗股价跌5.02%，广发基金旗下1只基金重仓，持有16.15万股浮亏损失44.41万元

Group 1 - The core point of the news is that Dabo Medical's stock has experienced a decline of 5.02% on October 17, with a cumulative drop of 7.15% over three consecutive days [1] - Dabo Medical, established on August 12, 2004, and listed on September 22, 2017, specializes in the production, research, and sales of high-value medical consumables [1] - The company's main business revenue composition includes trauma products (38.68%), spinal products (17.95%), minimally invasive surgical products (16.34%), joint products (10.37%), other products (9.27%), neurosurgical products (4.50%), and dental products (2.89%) [1] Group 2 - From the perspective of fund holdings, one fund under GF Fund has a significant position in Dabo Medical, with 161,500 shares held, accounting for 2.92% of the fund's net value [2] - The fund, GF Consumption Upgrade Stock (006671), has incurred a floating loss of approximately 444,100 yuan today and a total floating loss of 681,500 yuan during the three-day decline [2] - The fund was established on May 27, 2019, with a current scale of 200 million yuan, and has achieved a year-to-date return of 16.22% [2]